APOCYNIN PROTECTS AGAINST NEUROLOGICAL DAMAGE INDUCED BY QUINOLINIC ACID BY AN INCREASE IN GLUTATHIONE SYNTHESIS AND NRF2 LEVELS

作者：Cruz Alvarez Silvia; Santana Martinez Ricardo; Avila Chavez Euclides; Barrera Oviedo Diana; Hernandez Pando Rogelio; Pedraza Chaverri Jose; Maldonado Perla D^*

来源：Neuroscience, 2017, 350: 65-74.

DOI：10.1016/j.neuroscience.2017.03.011

• glutathione
• apocynin
• Nrf2 factor
• quinolinic acid

Apocynin (APO) is a well-known NADPH oxidase (NOX) inhibitor. However, several studies have reported its ability to increase glutathione (GSH) levels. Due to GSH is a major non-enzymatic antioxidant in brain, the aim of this study was to evaluate, in the striatum of control and quinolinic acid (QUIN) injected rats, the effect of APO administration on: (1) GSH levels, (2) activity of some enzymes involved in the GSH metabolism, and (3) nuclear factor erythroid-2-related factor 2 (Nrf2) mRNA levels. Animals received QUIN 240 nmol in right striatum and APO (5 mg/ kg, i.p.), 30 min before and 60 min after intrastriatal injection. APO treatment prevented the QUIN-induced histological damage to the striatum. In control rats, APO treatment increased GSH and Nrf2 mRNA levels and the activities of gamma-glutamylcysteine ligase (y-GCL), glutathione-S-transferase (GST) and glutathione peroxidase (GPx). On the other hand, APO treatment prevented the QUINinduced decrease in GSH and Nrf2 levels, and in y-GCL and GPx activities. These data indicate that APO is able to increase GSH levels and the activity of proteins involved in its metabolism, which could be associated with its ability to increase the Nrf2 mRNA levels.

• 出版日期2017-5-14